Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,887 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapy.
Ren J, Gwin WR, Zhou X, Wang X, Huang H, Jiang N, Zhou L, Agarwal P, Hobeika A, Crosby E, Hartman ZC, Morse MA, H Eng K, Lyerly HK. Ren J, et al. Oncoimmunology. 2016 Dec 7;6(4):e1264563. doi: 10.1080/2162402X.2016.1264563. eCollection 2017. Oncoimmunology. 2016. PMID: 28507788 Free PMC article.
Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study.
Jiang N, Qiao G, Wang X, Morse MA, Gwin WR, Zhou L, Song Y, Zhao Y, Chen F, Zhou X, Huang L, Hobeika A, Yi X, Xia X, Guan Y, Song J, Ren J, Lyerly HK. Jiang N, et al. Among authors: ren j. Clin Cancer Res. 2017 Sep 1;23(17):5066-5073. doi: 10.1158/1078-0432.CCR-17-0492. Epub 2017 Jun 13. Clin Cancer Res. 2017. PMID: 28611200 Clinical Trial.
Immune correlates of clinical benefit in a phase I study of hyperthermia with adoptive T cell immunotherapy in patients with solid tumors.
Qiao G, Wang X, Zhou X, Morse MA, Wu J, Wang S, Song Y, Jiang N, Zhao Y, Zhou L, Zhao J, Di Y, Zhu L, Hobeika A, Ren J, Lyerly HK. Qiao G, et al. Among authors: ren j. Int J Hyperthermia. 2019 Nov;36(sup1):74-82. doi: 10.1080/02656736.2019.1647350. Int J Hyperthermia. 2019. PMID: 31795830 Free article. Clinical Trial.
DC-CIK as a widely applicable cancer immunotherapy.
Wang S, Wang X, Zhou X, Lyerly HK, Morse MA, Ren J. Wang S, et al. Among authors: ren j. Expert Opin Biol Ther. 2020 Jun;20(6):601-607. doi: 10.1080/14712598.2020.1728250. Epub 2020 Feb 13. Expert Opin Biol Ther. 2020. PMID: 32033522 Review.
12,887 results
You have reached the last available page of results. Please see the User Guide for more information.